Logo image of RDIB

READING INTERNATIONAL INC-B (RDIB) Stock Fundamental Analysis

NASDAQ:RDIB - US7554082005 - Common Stock

12.6 USD
-0.49 (-3.74%)
Last: 8/29/2025, 4:30:01 PM
Fundamental Rating

1

Taking everything into account, RDIB scores 1 out of 10 in our fundamental rating. RDIB was compared to 75 industry peers in the Entertainment industry. Both the profitability and financial health of RDIB have multiple concerns. RDIB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year RDIB has reported negative net income.
RDIB had a negative operating cash flow in the past year.
RDIB had negative earnings in 4 of the past 5 years.
In the past 5 years RDIB always reported negative operating cash flow.
RDIB Yearly Net Income VS EBIT VS OCF VS FCFRDIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -6.08%, RDIB perfoms like the industry average, outperforming 42.67% of the companies in the same industry.
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDIB Yearly ROA, ROE, ROICRDIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

RDIB has a Gross Margin of 10.43%. This is in the lower half of the industry: RDIB underperforms 78.67% of its industry peers.
In the last couple of years the Gross Margin of RDIB has declined.
The Profit Margin and Operating Margin are not available for RDIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDIB Yearly Profit, Operating, Gross MarginsRDIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

0

2. Health

2.1 Basic Checks

RDIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDIB has more shares outstanding
Compared to 5 years ago, RDIB has more shares outstanding
The debt/assets ratio for RDIB is higher compared to a year ago.
RDIB Yearly Shares OutstandingRDIB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDIB Yearly Total Debt VS Total AssetsRDIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.09, we must say that RDIB is in the distress zone and has some risk of bankruptcy.
RDIB has a worse Altman-Z score (0.09) than 61.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC8.55%
RDIB Yearly LT Debt VS Equity VS FCFRDIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.23 indicates that RDIB may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.23, RDIB is doing worse than 86.67% of the companies in the same industry.
RDIB has a Quick Ratio of 0.23. This is a bad value and indicates that RDIB is not financially healthy enough and could expect problems in meeting its short term obligations.
RDIB has a worse Quick ratio (0.22) than 85.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
RDIB Yearly Current Assets VS Current LiabilitesRDIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.08% over the past year.
The Revenue has decreased by -5.48% in the past year.
RDIB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.33% yearly.
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)-5.48%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%

3.2 Future

Based on estimates for the next years, RDIB will show a very strong growth in Earnings Per Share. The EPS will grow by 28.82% on average per year.
RDIB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDIB Yearly Revenue VS EstimatesRDIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDIB Yearly EPS VS EstimatesRDIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDIB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDIB Price Earnings VS Forward Price EarningsRDIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RDIB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 299.36
RDIB Per share dataRDIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as RDIB's earnings are expected to grow with 28.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.75%
EPS Next 3Y28.82%

0

5. Dividend

5.1 Amount

RDIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

READING INTERNATIONAL INC-B

NASDAQ:RDIB (8/29/2025, 4:30:01 PM)

12.6

-0.49 (-3.74%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners46.89%
Inst Owner Change2.96%
Ins Owners6.33%
Ins Owner Change0%
Market Cap286.27M
Analysts80
Price Target22.5 (78.57%)
Short Float %0.03%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.92%
Min EPS beat(2)37.06%
Max EPS beat(2)48.79%
EPS beat(4)2
Avg EPS beat(4)-39.32%
Min EPS beat(4)-128.48%
Max EPS beat(4)48.79%
EPS beat(8)2
Avg EPS beat(8)-412.07%
EPS beat(12)3
Avg EPS beat(12)-293.3%
EPS beat(16)4
Avg EPS beat(16)-231.87%
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-7.5%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-6.33%
Min Revenue beat(4)-19.13%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-5.59%
Revenue beat(12)3
Avg Revenue beat(12)-5.44%
Revenue beat(16)4
Avg Revenue beat(16)-5.25%
PT rev (1m)26.6%
PT rev (3m)7.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.8%
EPS NY rev (1m)-12.22%
EPS NY rev (3m)9.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.26%
Revenue NY rev (1m)-2.1%
Revenue NY rev (3m)-4.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 299.36
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS9.05
BVpS-0.35
TBVpS-1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.43%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 82.92
Cap/Depr 25.78%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z 0.09
F-Score6
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.48%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A
EBIT growth 1Y-14.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year230.63%
EBIT Next 3Y63.32%
EBIT Next 5YN/A
FCF growth 1Y61.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.33%
OCF growth 3YN/A
OCF growth 5YN/A